GI/Bariatrics - Eli Lilly

Gastroenterology

Bariatrics

Status:

Enrolling

ClinicalTrials.gov:

NCT06362265

A Single Dose Study to Evaluate the Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus. A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

Age Range

10-17

Phase

Phase 1

Condition

(HbA1c) level of 6.5% to 9.5% (BMI) = to or < 45.0 kg/m2